RecruitingPhase 2NCT06958536
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Sponsor: Sanofi
St Louis, MO · +19 more sites
Crohn's Disease clinical trials in St Louis, MO
18 recruiting crohn's disease studies with a site in St Louis, MO.
RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
St Louis, MO · +59 more sites
RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Kansas City, MO · Liberty, MO · St Louis, MO · +84 more sites
RecruitingPhase 2NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Sponsor: Eli Lilly and Company
St Louis, MO · +13 more sites
RecruitingPhase 2NCT07483099
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Sponsor: Eli Lilly and Company
St Louis, MO · +13 more sites
RecruitingPhase 3NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Sponsor: Eli Lilly and Company
St Louis, MO · +10 more sites
RecruitingPhase 3NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Sponsor: Eli Lilly and Company
St Louis, MO · +34 more sites
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
City of Saint Peters, MO · Creve Coeur, MO · Kansas City, MO · +48 more sites
RecruitingPhase 3NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Columbia, MO · St Louis, MO · +59 more sites
RecruitingPhase 2NCT06548542
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Sponsor: AbbVie
Columbia, MO · Liberty, MO · St Louis, MO · +61 more sites
RecruitingPhase 3NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Sanofi
Liberty, MO · St Louis, MO · +122 more sites
RecruitingPhase 3NCT07184944
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Sanofi
Liberty, MO · St Louis, MO · +32 more sites
RecruitingPhase 4NCT06045754
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Sponsor: Takeda
Kansas City, MO · Liberty, MO · St Louis, MO · +38 more sites
RecruitingPhase 2NCT07625293
DB-3Q for the Treatment of Medically Refractory Crohn's Disease
Sponsor: Direct Biologics, LLC
St Louis, MO
RecruitingPhase 2NCT06976853
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
Sponsor: Washington University School of Medicine
St Louis, MO · +2 more sites
RecruitingPhase 2NCT06918808
DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease
Sponsor: Direct Biologics, LLC
St Louis, MO · +4 more sites
RecruitingPhase 1 / Phase 2NCT06721962
Treatment of Moderate to Severe Refractory Crohn's Disease
Sponsor: Tr1X, Inc.
St Louis, MO · +12 more sites
RecruitingPhase not listedNCT06670638
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
Sponsor: Alimentiv Inc.
St Louis, MO · +2 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.